> CPDR News
AUA 2007 Highlights
CPDR Presentations at the 102nd Annual AUA Meeting, held in Aneheim, California, May 19-24, 2007
June 27, 2007
The 102nd Annual Meeting of the American Urological Association (AUA) was held in Aneheim, California between May 19- 24 , 2007. The Annual Meeting of AUA is the world's largest meeting of urologic professionals, genitourinary pathologists and basic science urologic researchers.
The CPDR team was led by COL (ret) David McLeod, MD, CPDR Director and Chief, Urologic Oncology at the Walter Reed Army Medical Center, Dr. Isabell Sesterhenn, Chief, Genitourinary Pathology at the Armed Forces Institute of Pathology (AFIP) and Dr. Shiv Srivastava, PhD, CPDR Co-Director and Professor at Uniformed Services University.
Recognition of the CPDR presentations at the AUA Annual Meeting:
The poster “Evaluation of New Prostate Cancer Specific Secretory Protein Panel in Serum of Prostate Cancer Patients” presented by Dr. Kee-Hong Kim won the Best Poster Award in that session.
The poster “Quantitative Features of a Common TMPRSS2-ERG Fusion Transcript in Prostate Cancer” presented by Dr. ChunLing Gao and "Mapping of TMPRSS2-ERG Fusion in Multi-focal Prostate Cancer" presented by Dr. Chun Ling Gao and Dr. Bungo Furusato were selected in the Basic Science Highlights (5/23/07 morning) and listed as first among the top 10 abstracts listed in that session. The Basic Science Highlights webcast is accessible on the AUA web site (link).
Three CPDR National Database posters, including “Predicting Overall Survival Among Prostate Cancer Patients Treated With Primary Androgen Deprivation Therepy Versus Expectant Management” presented by Dr. Jennifer Cullen, were selected for podium presentation.
Presentations by the CPDR team included:
Prostate Cancer Basic Research (6 Moderated posters):
Mapping of TMPRSS2-ERG Fusion in Multi-focal Prostate Cancer (Dr. ChunLing Gao)
Quantitative Features of a Common TMPRSS2-ERG Fusion Transcript in Prostate Cancer (Dr. ChunLing Gao)
Mechanisms of Frequent Downregulation oF Lactotransferrin (LTF) in Prostate Cancer (Dr. Syed Shaheduzzaman)
Elevated Secreted Protein, Acidic, and Rich in Cysteine (SPARC) mRNA Expression in Neoplastic Prostate Epithelial Cells Correlates with PSA Recurrence after Radical Prostatectomy (Dr. Chad A. DeRosa)
Evaluation of New Prostate Cancer Specific Secretory Protein Panel in Serum of Prostate Cancer Patients (Dr. Kee-Hong Kim)
Magnetic Resonance Microscopy of Radical Prostatectomies at 7 Tesla (Dr. Bungo Furusato)
Epidemiology of prostate cancer (3 Podium and 2 Moderated posters):
PREDICTING OVERALL SURVIVAL AMONG PROSTATE CANCER PATIENTS TREATED WITH PRIMARY ANDROGEN DEPRIVATION THERAPY VERSUS EXPECTANT MANAGEMENT (Dr. Jennifer Cullen, podium presentation)
RETROSPECTIVE ANALYSIS OF PREOPERATIVE PARAMETERS THAT PREDICT POSITIVE SURGICAL MARGINS OR EXTRACAPSULAR EXTENSION FOLLOWING RADICAL PROSTATECTOMY USING THE CENTER FOR PROSTATE DISEASE RESEARCH DATABASE (co-author: Dr. J Cullen, podium presentation)
EFFECT OF OBESITY ON PSA RECURRENCE FOLLOWING RADIATION THERAPY USING 2006 PHOENIX CONSENSUS DEFINITION (co-author: Dr. J Cullen, podium presentation)
PREDICTING BIOCHEMICAL FAILURE IN MEN WITH LOW VOLUME (< 0.5CC) PROSTATE CANCER TREATED BY RADICAL PROSTATECTOMY (co-author: Dr. J Cullen)
THE IMPORTANCE OF PROSTATE CANCER TUMOR VOLUME IN MEN WITH PATHOLOGICALLY ORGAN CONFINED DISEASE (co-author: Dr. J Cullen).
The CPDR mission is fulfilled primarily through its three principal programs – the Clinical Research Center, the Basic Science Research Program and the National Multicenter Prostate Cancer Database– and through a robust education and training program that operates out of its Headquarters location, the Clinical Research Center, and the original laboratories at USUHS. CPDR is also committed to patient outreach, primarily through its affiliation with the WRAMC US TOO! organization and through a heavy schedule of health fairs in which it participates.
